172@29@17@140!~!172@29@0@53!~!|news|tags|dr-reddy.html!~!news|moneycontrol|com!~!|controller|tag.php!~!is_mobile=false
you are here: HomeNewsDr reddy
dr reddy
Jump to
134 Results Found
  • Cadila: a formidable play in Covid times and beyond Sep 25, 2020 09:39 AM IST

    Cadila: a formidable play in Covid times and beyond

    Cadila is not only a credible Indian pharma striving for a Covid solution, but on a longer time scale is an interesting watch in the large-cap space witnessing a significant transformation in product portfolio.

  • Ideas For Profit | Dr Reddy’s: An opportunity for risk takers May 21, 2020 01:30 PM IST

    Ideas For Profit | Dr Reddy’s: An opportunity for risk takers

    Primed by strong bets on complex pharma opportunities

  • Dr Reddy's to recall 1,752 bottles of heartburn drug in the US May 10, 2020 01:30 PM IST

    Dr Reddy's to recall 1,752 bottles of heartburn drug in the US

    Drug major Dr Reddy's Laboratories is recalling 1,752 bottles of generic heartburn medicine in the US after the American health regulator found quality issues with the product.

  • Dr Reddy's launches generic lipid-regulating tablets in US Apr 27, 2020 01:44 PM IST

    Dr Reddy's launches generic lipid-regulating tablets in US

    The company's tablets are available in 54 mg dose in bottle count size of 90, and 160 mg dose in bottle count sizes of 90 and 500

  • Rising stars? 14 stocks reported over 100% surge in PAT Dec 13, 2019 10:08 AM IST

    Rising stars? 14 stocks reported over 100% surge in PAT

    Experts feel there are only a handful of companies that could be considered for investment for the year 2020

  • Dr Reddy’s plummets 23% as Jefferies red flags ‘repeat’ observations Feb 15, 2019 10:46 AM IST

    Dr Reddy’s plummets 23% as Jefferies red flags ‘repeat’ observations

    According to a CNBC-TV18 report, Jefferies, in its research note, has said that the Form 483 issued by US Food and Drug Administration (US FDA) contains four repeat observations out of the total 11 observations.

  • Dr Reddy’s Labs falls 4% as US FDA issues 11 observations to Bachupally plant Feb 11, 2019 09:31 AM IST

    Dr Reddy’s Labs falls 4% as US FDA issues 11 observations to Bachupally plant

    The company on Friday told the exchanges that its Formulations Manufacturing Plant - 3 at Bachupally, Hyderabad had been inspected by the US FDA. It has been issued a Form 483 with 11 observations.

  • Upbeat CLSA view, procedural observations from US FDA send DRL stock up 3% Sep 20, 2017 12:38 PM IST

    Upbeat CLSA view, procedural observations from US FDA send DRL stock up 3%

    The global broking firm also observed that three products, Nuvaring, Suboxone & Copaxone will be major contributors over FY19-20. In fact, the EPS for FY20 could see an upside of 44 percent to Rs 210 if these products are introduced.

  • Dr Reddy’s tanks 6% on dismal Q1; brokerages turn cautious on stock Jul 28, 2017 12:16 PM IST

    Dr Reddy’s tanks 6% on dismal Q1; brokerages turn cautious on stock

    Say headwinds in US hit financials, highlight further risks in terms of remediation delays at its plants.

  • Dr Reddy’s US FDA developments get a thumbs up from brokerages Jun 15, 2017 01:32 PM IST

    Dr Reddy’s US FDA developments get a thumbs up from brokerages

    Cite positive news on the regulatory front, but pain for Duvvada plant may remain, they say.

  • Dr Reddy's Labs Q4: Analysts see hope in US biz recovery, reduced regulatory concerns May 15, 2017 03:54 PM IST

    Dr Reddy's Labs Q4: Analysts see hope in US biz recovery, reduced regulatory concerns

    Brokerages largely remain optimistic about the pharma major’s improvement in US business as well as reduced regulatory risks, while some also highlight the seriousness of US FDA’s observations at some of its plants.

  • What changed for the market while you were sleeping? 10 things to know Apr 05, 2017 07:48 AM IST

    What changed for the market while you were sleeping? 10 things to know

    Fourth quarter earnings from India Inc. along with the Reserve Bank of India’s policy stance on rates will decide the trend for the market in this week.

  • Buzz of Unichem Labs looking for a buyer sends stock up 4% Mar 10, 2017 03:01 PM IST

    Buzz of Unichem Labs looking for a buyer sends stock up 4%

    Sources told CNBC-TV18 that it has received interest from domestic and global companies for the sale.

  • Nifty below 8550, Sensex in red; Jaitley to present Budget soon Feb 01, 2017 10:20 AM IST

    Nifty below 8550, Sensex in red; Jaitley to present Budget soon

    SBI, Maruti, HDFC, BHEL and ITC are top gainers while TCS, Infosys, Wipro, Dr Reddy's and NTPC are losers in the Sensex.

  • Nifty below 8150, Sensex falls over 100 pts; SBI, HDFC down 1-2% Jan 02, 2017 09:15 AM IST

    Nifty below 8150, Sensex falls over 100 pts; SBI, HDFC down 1-2%

    The market has started 2017 on a flat note as the Sensex is up 55.14 points or 0.2 percent at 26681.60. The Nifty is up 19.10 points or 0.2 percent at 8204.90. About 334 shares have advanced, 72 shares declined, and 3221 shares are unchanged.

  • Nifty still below 8100, Sensex firm; Axis Bank, Coal India up 2% Dec 28, 2016 12:00 PM IST

    Nifty still below 8100, Sensex firm; Axis Bank, Coal India up 2%

    Axis Bank, Wipro, Coal India, Dr Reddy's Labs and Asian Paints are top gainers while Tata Steel, Reliance, Tata Motors and Bharti are losers in the Sensex.

  • Sensex, Nifty firm; Asian Paints, TCS, Bajaj Auto top gainers Nov 16, 2016 01:00 PM IST

    Sensex, Nifty firm; Asian Paints, TCS, Bajaj Auto top gainers

    Asian Paints, TCS, Bajaj Auto, M&M and Hero MotoCorp are top gainers while Dr Reddy's Labs, ITC, Lupin, Cipla and GAIL are losers in the Sensex.

  • Sensex falls over 150, Nifty opens below 8650; Axis tanks 7% Oct 26, 2016 09:15 AM IST

    Sensex falls over 150, Nifty opens below 8650; Axis tanks 7%

    Bharti Airtel, Hero MotoCorp, Adani Ports, Maruti and Dr Reddy's are top gainers while Axis Bank, ICICI Bank, Tata Motors, GAIL and Wipro are losers in the Sensex.

  • Sensex, Nifty still under pressure; Dr Reddy's Labs up 1% Oct 25, 2016 11:00 AM IST

    Sensex, Nifty still under pressure; Dr Reddy's Labs up 1%

    Dr Reddy's Labs, Axis Bank, Sun Pharma, Cipla and Maruti are top gainers while Tata Steel, GAIL, HUL, TCS and M&M are losers in the Sensex.

  • Sensex, Nifty flat; ONGC, Axis Bank, M&M drag 1% Oct 05, 2016 11:00 AM IST

    Sensex, Nifty flat; ONGC, Axis Bank, M&M drag 1%

    Asian Paints, HUL, SBI, Tata Motors and Maruti are top gainers while ONGC, Axis Bank, M&M, Wipro and Dr Reddy's are losers in the Sensex.

  • Sensex, Nifty steady; GAIL & ONGC gain 4%, L&T down 1% Oct 04, 2016 11:00 AM IST

    Sensex, Nifty steady; GAIL & ONGC gain 4%, L&T down 1%

    GAIL, ONGC, Cipla, Tata Steel and Reliance are top gainers while Coal India, L&T, Axis Bank, M&M and Dr Reddy's Labs are losers in the Sensex.

  • Sensex, Nifty open flat; L&T, Reliance, M&M early gainers Sep 23, 2016 09:25 AM IST

    Sensex, Nifty open flat; L&T, Reliance, M&M early gainers

    L&T, Reliance, M&M, Dr Reddy's and Sun Pharma are top gainers while Axis Bank, Infosys, Bharti, Tata Motors and Hero MotoCorp are losers in the Sensex.

  • Sensex up over 300pts, Nifty eyes 8900 post Fed meet; banks up Sep 22, 2016 09:15 AM IST

    Sensex up over 300pts, Nifty eyes 8900 post Fed meet; banks up

    The Sensex is up 323.91 points or 1.1 percent at 28831.33 and the Nifty is up 107.10 points or 1.2 percent at 8884.25. About 924 shares have advanced, 99 shares declined, and 32 shares are unchanged.

  • Sensex, Nifty continue to rise; Tata Motors, Axis Bank up 3% Aug 12, 2016 11:00 AM IST

    Sensex, Nifty continue to rise; Tata Motors, Axis Bank up 3%

    Tata Motors, Axis Bank, Tata Steel, Reliance and BHEL are top gainers while Infoys, Bharti Airtel, Adani Ports and Dr Reddy's Labs are losers in the Sensex.

  • Sensex, Nifty continue to be under pressure; IT stocks rally Aug 01, 2016 01:00 PM IST

    Sensex, Nifty continue to be under pressure; IT stocks rally

    TCS, Wipro, Maruti, Bajaj Auto and Dr Reddy's Labs are top gainers while ICICI Bank, L&T, Adani Ports, BHEL and Lupin are losers in the Sensex.

Sections